Adherence to disease-modifying therapies in patients with multiple sclerosis

References

• LerayEMoreauTFromontAEdanGEpidemiology of multiple sclerosisRev Neurol2016172131326718593
   PubMed Web of Science ®Google Scholar
• BrolaWFudalaMFlagaSRyglewiczDPotemkowskiAPolski rejestr chorych na stwardnienie rozsiane – stan obecny, perspektywy i problemy [Polish registry of multiple sclerosis patients – current status, perspectives and problems]Aktualn Neurolo20151526873 Polish
   Google Scholar
• BrozekPBrachmanskaMRabiczkoKBulskaWCiulkowiczMKrzystanekEDepression, sleep disturbances and anxiety in patients with relapsing-remitting multiple sclerosis: a longitudinal cohort observationPsychiatr Danub201729Suppl 346446828953809
   PubMed Web of Science ®Google Scholar
• BrownePChandraratnaDAngoodCAtlas of Multiple Sclerosis 2013: A growing global problem with widespread inequityNeurology201483111022102425200713
   PubMed Web of Science ®Google Scholar
• ArroyoEGrauCRamoCParraJSánchez-SoliñoOpor el grupo espanol del estudio GAPGlobal adherence project to disease-modifying therapies in patients with relapsing multiple sclerosis: 2-year interim resultsNeurologia201025743544220964990
   PubMed Web of Science ®Google Scholar
• di BattistaGBertolottoAGasperiniCGhezziAMaimoneDSolaroCMultiple Sclerosis State of the Art (SMART): a qualitative and quantitative analysis of therapy’s adherence, hospital reliability’s perception, and services provided qualityMult Scler Int20142014319
   Google Scholar
• OžuraAKovačLSegaSAdherence to disease-modifying therapies and attitudes regarding disease in patients with multiple sclerosisClin Neurol Neurosurg2013115S6S1124321157
   PubMed Web of Science ®Google Scholar
• DecooDVokaerMTreatment adherence in multiple sclerosis: a survey of Belgian neurologistsPatient Prefer Adherence201591669167626640373
   PubMed Web of Science ®Google Scholar
• World Health OrganizationInnovative Care for Chronic Conditions: Building Blocks for Action: Global ReportsGeneva, SwitzerlandWHO2002
   Google Scholar
• WicksPMassagliMKulkarniADastaniHUse of an online community to develop patient-reported outcome instruments: the Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ)J Med Internet Res2011131e1221266318
   PubMed Web of Science ®Google Scholar
• EvansCMarrieRAZhuFAdherence to disease-modifying therapies for multiple sclerosis and subsequent hospitalizations: MS adherence and hospitalizationsPharmacoepidemiol Drug Saf201726670271128370875
   PubMed Web of Science ®Google Scholar
• BurksJMarshallTSYeXAdherence to disease-modifying therapies and its impact on relapse, health resource utilization, and costs among patients with multiple sclerosisClin Outcomes Res20179251260
   PubMed Web of Science ®Google Scholar
• MckayKATremlettHPattenSBDeterminants of nonadherence to disease-modifying therapies in multiple sclerosis: A cross-Canada prospective studyMult Scler J2017234588596
   Web of Science ®Google Scholar
• BeerKMüllerMHew-WinzelerAMThe prevalence of injection-site reactions with disease-modifying therapies and their effect on adherence in patients with multiple sclerosis: an observational studyBMC Neurol201111114422074056
   PubMed Web of Science ®Google Scholar
• DevonshireVLapierreYMacdonellRThe Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosisEur J Neurol2011181697720561039
   PubMed Web of Science ®Google Scholar
• RoudbaryS-AYousefzadeh-ChabokSBehzadniaHNonadherence to disease-modifying treatments in patients with multiple sclerosisCasp J Neurol Sci2017310128134
   Google Scholar
• HansenKSchüsselKKiebleMAdherence to disease modifying drugs among patients with multiple sclerosis in Germany: a retrospective cohort studyPLoS One2015107e013327926214805
   PubMed Web of Science ®Google Scholar
• EvansCMarrieRAZhuFAdherence and persistence to drug therapies for multiple sclerosis: A population-based studyMult Scler Relat Disord20168788527456879
   PubMed Web of Science ®Google Scholar
• PatientsLikeMePolish version of MS-TAQ questionnaire Available from: https://www.openresearchexchange.com/public/library/instruments/30/overviewAccessed September 2, 2017 Polish
   Google Scholar
• CramerJARoyABurrellAMedication compliance and persistence: terminology and definitionsValue Health2008111444718237359
   PubMed Web of Science ®Google Scholar
• HigueraLCarlinCSAndersonSAdherence to disease-modifying therapies for multiple sclerosisJ Manag Care Spec Pharm201622121394140127882830
   PubMed Web of Science ®Google Scholar
• HalpernRAgarwalSDembekCBortonLLopez-BresnahanMComparison of adherence and persistence among multiple sclerosis patients treated with disease-modifying therapies: a retrospective administrative claims analysisPatient Prefer Adherence20115738421423591
   PubMed Web of Science ®Google Scholar
• MikolDLopez-BresnahanMTaraskiewiczSChangPRangnowJRebiject Study GroupA randomized, multicentre, open-label, parallel-group trial of the tolerability of interferon beta-1a (Rebif) administered by autoinjection or manual injection in relapsing-remitting multiple sclerosisMult Scler200511558559116193898
   PubMed Web of Science ®Google Scholar
• PoorjavadMDerakhshandehFEtemadifarMSoleymaniBMinagarAMaghziAHOropharyngeal dysphagia in multiple sclerosisMult Scler J2010163362365
   Web of Science ®Google Scholar
• FernandesAMDupratACEckleyCASilvaLFerreiraRBTilberyCPOropharyngeal dysphagia in patients with multiple sclerosis: do the disease classification scales reflect dysphagia severity?Braz J Otorhinolaryngol201379446046523929146
   PubMed Web of Science ®Google Scholar
• KöşkderelioğluAGedizlioğluMOrtanPÖcekÖEvaluation of the adherence to immunmodulatory treatment in patients with multiple sclerosisNoro Psikiyatr Ars201552437637928360743
   PubMedGoogle Scholar
• SpessottoCVCavalliHEboniACPatients’ satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosisArq Neuropsiquiatr201674861762027556371
   PubMed Web of Science ®Google Scholar
• GlanzBIMusallamARintellDJChitnisTWeinerHLHealyBCTreatment satisfaction in multiple sclerosisInt J MS Care2014162687525061430
   PubMedGoogle Scholar